M‐CSF directs myeloid and NK cell differentiation to protect from CMV after hematopoietic cell transplantation
PK Kandalla, J Subburayalu, C Cocita… - EMBO Molecular …, 2023 - embopress.org
Therapies reconstituting autologous antiviral immunocompetence may represent an
important prophylaxis and treatment for immunosuppressed individuals. Following …
important prophylaxis and treatment for immunosuppressed individuals. Following …
Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem …
KP Micklethwaite, L Clancy, U Sandher… - Blood, The Journal …, 2008 - ashpublications.org
Cytomegalovirus (CMV) and its therapy continue to contribute to morbidity and mortality in
hemopoietic stem cell transplantation (HSCT). Many studies have demonstrated the …
hemopoietic stem cell transplantation (HSCT). Many studies have demonstrated the …
[HTML][HTML] Mutual interference between cytomegalovirus and reconstitution of protective immunity after hematopoietic cell transplantation
MJ Reddehase - Frontiers in immunology, 2016 - frontiersin.org
Hematopoietic cell transplantation (HCT) is a therapy option for aggressive forms of
hematopoietic malignancies that are resistant to standard antitumoral therapies …
hematopoietic malignancies that are resistant to standard antitumoral therapies …
Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation
Background. The profound immunodeficiency associated with allogeneic hematopoietic
stem cell transplantation is permissive to uncontrolled replication of latent human …
stem cell transplantation is permissive to uncontrolled replication of latent human …
[HTML][HTML] Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model
MS Smith, DC Goldman, AS Bailey, DL Pfaffle… - Cell host & …, 2010 - cell.com
Human cytomegalovirus (HCMV) is a significant cause of morbidity and mortality in organ
transplant recipients. The use of granulocyte-colony stimulating factor (G-CSF)-mobilized …
transplant recipients. The use of granulocyte-colony stimulating factor (G-CSF)-mobilized …
Paracrine inhibition of GM-CSF signaling by human cytomegalovirus in monocytes differentiating to dendritic cells
J Carlier, H Martin, B Mariamé… - Blood, The Journal …, 2011 - ashpublications.org
A primary HCMV infection or virus reactivation may cause severe disease in hosts with a
deficient immune system. The virus can disturb both innate and adaptive immunity by …
deficient immune system. The virus can disturb both innate and adaptive immunity by …
Kinetics of interferon‐gamma producing cytomegalovirus (CMV)‐specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic …
AJ Eid, RA Brown, WJ Hogan, BD Lahr… - Transplant Infectious …, 2009 - Wiley Online Library
Background. Deficiencies in cytomegalovirus (CMV)‐specific T lymphocytes impair the
immunologic response against CMV reactivation after allogeneic hematopoietic stem cell …
immunologic response against CMV reactivation after allogeneic hematopoietic stem cell …
Linking indirect effects of cytomegalovirus in transplantation to modulation of monocyte innate immune function
Cytomegalovirus (CMV) is an important cause of morbidity and mortality in the
immunocompromised host. In transplant recipients, a variety of clinically important “indirect …
immunocompromised host. In transplant recipients, a variety of clinically important “indirect …
[HTML][HTML] An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation
N Tormo, C Solano, R de la Cámara… - Biology of Blood and …, 2010 - Elsevier
Human herpesvirus-6 (HHV-6) may enhance cytomegalovirus (CMV) replication in
allogeneic stem cell transplant (allo-SCT) recipients either through direct or indirect …
allogeneic stem cell transplant (allo-SCT) recipients either through direct or indirect …
Immune control of cytomegalovirus reactivation in stem cell transplantation
MA Degli-Esposti, GR Hill - Blood, The Journal of the American …, 2022 - ashpublications.org
The reactivation of viruses from latency after allogeneic stem cell transplantation (SCT)
continues to represent a major clinical challenge requiring sophisticated monitoring …
continues to represent a major clinical challenge requiring sophisticated monitoring …